ECE inhibitors (Schering-Plough)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameECE inhibitors (Schering-Plough)
Drug Alias Nameendothelin converting enzyme inhibitors (Schering-Plough)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin-converting enzymes inhibitors
TargetsEndothelin-converting enzymes
Therapy Area/IndicationsPeripheral Vascular DiseasesCardiovascular DiseasesCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough Research Institute
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesCardiovascular DiseasesCerebrovascular Disorders

Other Information

ATC CodeN/A
Related LinksN/A